Notification of Abstract Status
All individuals listed as Submitting Authors will be notified of acceptance or rejection by email. Reviewing should be finalized in late August, and notifications will be sent by August 24 to the email address provided for the abstract submitter at the time of submission. If an abstract is not selected for presentation, the presenter may request a full refund of the registration fee.

Presentation and Publication
The titles and presenting authors of all regular abstracts scheduled for presentation at this conference will be available online prior to the conference. With the exception of abstracts selected for a conference press program (if applicable), all conference abstracts will not be available until the Conference App is released on September 16. Abstracts will be available online as a supplement to the AACR journal, Cancer Immunology Research, within 2-3 months of the conference. Every effort will be made to reproduce the content of the abstracts as submitted, except in certain circumstances where changes may be made to comply with the conference style guide.

Poster boards dimensions will be provided in email correspondence to the Submitting Authors.  The organizers will provide poster numbers and pushpins.

From the accepted posters, a small number of highly rated abstract authors will also be invited to deliver short oral presentations of their work during the general sessions.  All abstracts will be considered.  Instructions will be sent to the Submitting Authors with the date, time, and format for these presentations.

Conference Registration
Presenting Authors must register for the conference and attend the session in which the abstract is scheduled to discuss the research in detail, according to the specific guidelines of the session.  If an abstract is not accepted, the presenter may request a full refund of the registration fee.

Request for Withdrawal
Once an abstract has been submitted, it may be withdrawn only by written request from the Submitting Author.  The request may be sent by email to abstracts@cancerimmunotherapyconference.org and must be received at least 30 days prior to the start of the conference.

If due to unforeseen circumstances the designated Presenting Author is unavailable to attend the session to present the abstract, the Submitting Author must contact abstracts@cancerimmunotherapyconference.org to designate a co-author to serve as the Presenting Author. If no authors are available to present the abstract, the Submitting Author must withdraw the abstract immediately by emailing abstracts@cancerimmunotherapyconference.org

Submission
Abstract submissions are only accepted through the online abstract submission platform. Paper abstracts are not accepted. Only those abstracts that have been reviewed and selected by the Scientific Planning Committee may be presented. Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. The organizers do not proofread or correct spelling, typographical, grammatical, or scientific errors, nor can changes be made once the abstract is submitted. For technical questions or if you have policy related questions, please contact the abstract submission help desk at
abstracts@cancerimmunotherapyconference.org

Abstract Categories

  • Clinical Trials of Cancer Immunotherapies
  • Convergence of Technology and Cancer Immunotherapy
  • Genetically Engineered T Cells
  • Maintenance of Immune Balance: Effects of Targeted and Immune Therapies
  • Microbiome and Metabolism
  • Mutational Analysis and Predicting Response to Immunotherapy
  • Novel Vaccine Platforms and Combinations
  • Regulating T Cells and Their Response to Cancer
  • Tackling the Tumor Microenvironment - Beyond T Cells
  • Trials in Progress
  • Other